Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
1 Introduction Chimeric antigen receptor T (CAR-T) cell therapy is a pivotal innovation in the field of targeted immunotherapy, allowing for the direct recognition of tumor-associated antigens (TAAs) without requiring major histocompatibility complex (MHC)-mediated antigen presentation ( SLE is a severe autoimmune disorder, affecting primarily women of childbearing age with a prevalence of 0.1% in the general population ( With the advancement of innovative immunotherapies, CAR T-cell therapy holds great potential for treating patients with refractory SLE ( + B cells or BCMA + plasma cells or double-positive plasmablasts ( Taken together, this review aims to evaluate the potential of CAR-T cell therapy in treating SLE\-related diseases
C.DuarteA
When glutathione levels are inadequate, the immune system can become dysregulated, either becoming overactive (increasing inflammation and risk of autoimmune disorders) or underactive (reducing the body's ability to fight infections)
materia rozpuszczony przechowuje si w 28C typowo do 28 dni, bez cykli zamraania-rozmraania
Authors contributions Razia Sardar and Fatima Sardar contributed to the conception and design of the study
US$ 26.40
US$ 26.05
US$ 26.61
US$ 28.09
US$ 24.71
US$ 26.16
US$ 22.72